Relmapirazin
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2013 (NCT02098174)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
Nc1nc(C(=O)N[C@H](CO)C(=O)O)c(N)nc1C(=O)N[C@H](CO)C(=O)O- Mol. weight
- 372.29 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1949708 ↗
Also known as
- mp-3180
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07080008 | Phase 1 | Jan 31, 2026 | MediBeacon |
| NCT05943977 | Phase 3 | Mar 2, 2023 | Hangzhou Zhongmei, MediBeacon, Soochow University, Xuzhou Medical University |
| NCT02098187 | Phase 1 | Mar 1, 2014 | MediBeacon |
| NCT02098174 | Phase 1 | Nov 1, 2013 | MediBeacon, University of Maryland |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MediBeacon | For profit | 4 | 3 | 2 | 2013 |
| Hangzhou Zhongmei | For profit | 1 | 1 | 1 | 2023 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Xuzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
5 organizations
Page 1 / 1